Literature DB >> 2806416

Immunosuppression and mycobacteria other than Mycobacterium tuberculosis: results from patients with and without HIV infection.

M Peters1, D Schürmann, A C Mayr, R Heterzer, H D Pohle, B Ruf.   

Abstract

Infections caused by mycobacteria other than Mycobacterium tuberculosis (MOTT) have often been described as common in AIDS patients. To evaluate whether infections with MOTT are specific for HIV related immunosuppression or are also frequent in patients with immunosuppression of different aetiology, data on the frequency of isolation from immunosuppressed patients with HIV infection are important. Blood, stool and urine specimens from 134 patients with non-HIV related immunosuppression, and from 55 immunocompetent subjects were examined for mycobacteria. MOTT have been isolated from one immunocompetent person but from none of the immunosuppressed patients. Since in AIDS patients an initial colonization of the gastrointestinal tract (GI-tract) with MOTT is common, GI-tract biopsy specimens from an additional 80 patients were examined microscopically and histologically for mycobacteria. Mycobacteria were not isolated from these specimens. In the same period of time 72 AIDS patients have been examined; 7 (10%) had infections with M. tuberculosis whereas MOTT have been isolated from 16 (22%) of these patients. Mycobacteria have been found only rarely in immunocompetent patients and have not been isolated from patients with non-HIV related immunosuppression. The isolation of MOTT is highly correlated with an HIV-related immunosuppression.

Entities:  

Mesh:

Year:  1989        PMID: 2806416      PMCID: PMC2249508          DOI: 10.1017/s095026880003065x

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  31 in total

1.  Isolation of "atypical" mycobacteria from healthy persons.

Authors:  L B EDWARDS; C E PALMER
Journal:  Am Rev Respir Dis       Date:  1959-11

2.  [Diagnostic and therapeutic progress in nontuberculous mycobacterioses].

Authors:  K L Radenbach
Journal:  Prax Klin Pneumol       Date:  1985-02

3.  Mycobacterium avium-Mycobacterium intracellulare from the intestinal tracts of patients with the acquired immunodeficiency syndrome: concepts regarding acquisition and pathogenesis.

Authors:  B Damsker; E J Bottone
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

4.  Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop.

Authors:  J F Murray; C P Felton; S M Garay; M S Gottlieb; P C Hopewell; D E Stover; A S Teirstein
Journal:  N Engl J Med       Date:  1984-06-21       Impact factor: 91.245

5.  Gastrointestinal manifestations of the acquired immunodeficiency syndrome: a review of 22 cases.

Authors:  B Dworkin; G P Wormser; W S Rosenthal; S K Heier; M Braunstein; L Weiss; R Jankowski; D Levy; S Weiselberg
Journal:  Am J Gastroenterol       Date:  1985-10       Impact factor: 10.864

6.  Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics.

Authors:  T E Kiehn; F F Edwards; P Brannon; A Y Tsang; M Maio; J W Gold; E Whimbey; B Wong; J K McClatchy; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

7.  Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida.

Authors:  A E Pitchenik; C Cole; B W Russell; M A Fischl; T J Spira; D E Snider
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

Review 8.  Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature.

Authors:  C R Horsburgh; U G Mason; D C Farhi; M D Iseman
Journal:  Medicine (Baltimore)       Date:  1985-01       Impact factor: 1.889

9.  Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome.

Authors:  A M Macher; J A Kovacs; V Gill; G D Roberts; J Ames; C H Park; S Straus; H C Lane; J E Parrillo; A S Fauci
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

10.  Humoral response to disseminated infection by Mycobacterium avium-Mycobacterium intracellulare in acquired immunodeficiency syndrome and hairy cell leukemia.

Authors:  S M Winter; E M Bernard; J W Gold; D Armstrong
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

View more
  9 in total

Review 1.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

Review 2.  Agents of newly recognized or infrequently encountered mycobacterial diseases.

Authors:  L G Wayne; H A Sramek
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

Review 3.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Novel algorithm identifies species in a polymycobacterial sample by fluorescence capillary electrophoresis-based single-strand conformation polymorphism analysis.

Authors:  Tomotada Iwamoto; Toshiaki Sonobe; Kozaburo Hayashi
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

5.  Clinical usefulness of serological measurements obtained by antigen 60 in mycobacterial infections: development of a new concept.

Authors:  R Maes
Journal:  Klin Wochenschr       Date:  1991-10-02

6.  Culture of Mycobacterium kansasii in the blood of an HIV negative patient.

Authors:  D Veale; D Fishwick; J E White; A D Gascoigne; K Gould; P A Corris
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

7.  Nontuberculous mycobacterial infection in HIV-negative patients receiving immunosuppressive therapy.

Authors:  K Skogberg; P Ruutu; P Tukiainen; V V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

8.  Experimental inoculation of BFDV-positive budgerigars (Melopsittacus undulatus) with two Mycobacterium avium subsp. avium isolates.

Authors:  Aleksandra Ledwoń; Rafał Sapierzyński; Ewa Augustynowicz-Kopeć; Piotr Szeleszczuk; Marcin Kozak
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411

9.  Heme oxygenase-1 promotes granuloma development and protects against dissemination of mycobacteria.

Authors:  Doron Regev; Ranu Surolia; Suman Karki; Jason Zolak; Ana Montes-Worboys; Ocatvio Oliva; Purushotum Guroji; Vikram Saini; Adrie Jc Steyn; Anupam Agarwal; Veena B Antony
Journal:  Lab Invest       Date:  2012-09-10       Impact factor: 5.662

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.